ARS Pharmaceuticals SPRY
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 10.05 | 103.99 | -0.52 | -53,192 | -51 | |
| 2025Q2 | 17.45 | 106.08 | -0.46 | -47,614 | -45 | |
| 2025Q1 | 12.58 | 109.54 | 154.33 | -0.35 | -37,177 | -34 |
| 2024Q4 | 10.55 | 93.98 | 0.51 | 47,197 | 50 | |
| 2024Q3 | 14.50 | 113.70 | -0.19 | -21,748 | -19 | |
| 2024Q2 | 8.51 | 122.56 | -0.13 | -15,340 | -13 | |
| 2024Q1 | 10.22 | 128.18 | -0.11 | -13,192 | -10 | |
| 2023Q4 | 5.48 | 142.66 | -0.07 | -10,226 | -7 | |
| 2023Q3 | 3.78 | 120.93 | -0.16 | -17,978 | -15 | |
| 2023Q2 | 6.70 | 118.61 | -0.18 | -20,603 | -17 | |
| 2023Q1 | 6.51 | 125.08 | -0.16 | -18,713 | -15 | |
| 2022Q4 | 8.53 | 107.03 | -0.21 | -15,443 | -14 | |
| 2022Q3 | 5.28 | 99.90 | -0.21 | -18,939 | -18 | |
| 2022Q2 | 4.24 | 98.82 | -0.21 | -6,344 | -6 | |
| 2022Q1 | 3.51 | 97.92 | -0.24 | -7,099 | -7 | |
| 2021Q4 | 6.66 | 1.19 | -23,507 | -23 |